Back to Scanner
AKTS
NASDAQRS 3Score 15Aktis Oncology, Inc.
HealthcareBiotechnology$925.77M1 setup passing
$17.06
-1.8% ($0.31)
-41.5% from 52W High
P/E (TTM)
—
Fwd P/E
—
PEG
—
Analyst Upside
+81.7%
EPS Growth
—
Gross Margin
100.0%
ROE
19.5%
D/E
-0.08
Div Yield
0.0%
Avg Volume
380.4K
Price Chart
Key Levels
SMA 200
$19.34
SMA 50
$19.12
Price
$17.06
52W High
$29.16
Target
$31.00
Setup Radar
1/8 passing📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
⚡
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst